Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 70771-1527

5 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 70771-1527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E7389f3e 074b 44ca B767 5520390265e5 01)

Image (E7389f3e 074b 44ca B767 5520390265e5 01)
Chemical structure diagram of Propafenone Hydrochloride, illustrating its molecular framework with aromatic rings and functional groups.*
FDA Label Image

Image (E7389f3e 074b 44ca B767 5520390265e5 02)

Image (E7389f3e 074b 44ca B767 5520390265e5 02)
A Kaplan-Meier plot illustrating the proportion of patients without event over time (days up to 300) for Propafenone Hydrochloride extended-release capsules (225 mg, 325 mg, and 425 mg twice daily doses) compared to placebo. The graph shows the survival curves for each group, with number of patients at risk noted below the x-axis and p-values indicating statistical significance for the comparisons.*
FDA Label Image

Label (E7389f3e 074b 44ca B767 5520390265e5 03)

Label (E7389f3e 074b 44ca B767 5520390265e5 03)
Propafenone Hydrochloride Extended-release Capsules USP 225 mg label with NDC 70771-1525-6, showing 60 capsules in the package. The label includes warnings about seal integrity, storage conditions, child resistance, and manufacturer details as Zydus Lifesciences Ltd., Ahmedabad, India. The label features a barcode and branding with the Zydus logo.*
FDA Label Image

Label (E7389f3e 074b 44ca B767 5520390265e5 04)

Label (E7389f3e 074b 44ca B767 5520390265e5 04)
Packaging label for Propafenone Hydrochloride Extended-release Capsules USP, 325 mg strength, in a 60-capsule container. The label indicates the product is Rx only and is manufactured by Zydus Lifesciences Limited. It includes storage instructions, cautions about the seal, and that the package is child-resistant. The label also displays the NDC 70771-1526-6 and the Zydus logo.*
FDA Label Image

Label (E7389f3e 074b 44ca B767 5520390265e5 05)

Label (E7389f3e 074b 44ca B767 5520390265e5 05)
Label for Propafenone Hydrochloride Extended-release Capsules, USP 425 mg, showing a bottle label with the product name, strength, and dosage form prominently in black and an orange box. It indicates 60 capsules, prescription only, with storage instructions, a child-resistant package note, and the manufacturer Zydus Lifesciences Ltd., Ahmedabad, India. The NDC 70771-1527-6 and barcode are displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.